Healthcare & Life Sciences
Nectin Therapeutics
Israel
series-a
series-a
Stage
1
Investors
About
Nectin Therapeutics develops immunotherapeutic biologic drugs targeting receptors in the nectin protein family to treat solid and hematological cancers by overcoming tumor inhibitory pathways and enabling immune cells to destroy cancer cells.
Explore Nectin Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.